TWIST BIOSCIENCE CORPORATION
|
681 Gateway Blvd. South San Francisco, CA 94080 |
December 12, 2019
VIA EDGAR
U.S. Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
| Attn: | Chris Edwards, Office of Life Sciences |
| Re: | Twist Bioscience Corporation Acceleration Request |
Acceleration Request
| Requested Date: | December 13, 2019 | |||||
| Requested Time: | 4:30 p.m. Eastern Time |
Ladies and Gentlemen:
Twist Bioscience Corporation (the “Company”) hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to declare the Company’s Registration Statement on Form S-3 (File No. 333-234538), as amended, effective at the “Requested Date” and “Requested Time” set forth above or as soon thereafter as practicable.
The Company hereby authorizes Andrew D. Thorpe, who is an attorney with the Company’s outside legal counsel, Orrick, Herrington & Sutcliffe LLP, to orally modify or withdraw this request for acceleration.
The Company requests that it be notified of such effectiveness by a telephone call to Mr. Thorpe at (415) 773-5970.
[Signature page follows]
| Sincerely,
TWIST BIOSCIENCE CORPORATION
| ||
| By: | /s/ Mark Daniels Name: Mark Daniels Title: Chief Legal Officer, Secretary and Chief Ethics and Compliance Officer | |
| cc: | Emily M. Leproust, Ph.D., Twist Bioscience Corporation |
Andrew D. Thorpe, Esq., Orrick, Herrington & Sutcliffe, LLP
Melissa V. Frayer, Esq., Orrick, Herrington & Sutcliffe, LLP